Melbourne, Australia (10 May 2013). Verva Pharmaceuticals Ltd. (”Verva”; ACN 074 636 847) is pleased to announce that the Annual General Meeting of Verva shareholders will be held on Friday 31 May, 2013 at 9:00 am in the offices of K&L Gates LLP, Level 25, 525 Collins Street, Melbourne, Victoria, Australia.
The Notice of Meeting and Proxy form for the AGM have been mailed to shareholders and are available on-line. Verva’s Annual Report for the year ending 31 December 2012, including audited financial statements, is also available on the Verva website (Verva 2012 Annual Report). A hard copy is available upon request.